Metraipolis › archive › dc_20a1df330bce

An integrated in-silico approach for drug target identification in human pathogen Shigella dysenteriae — Europe PMC PMID:38753867

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38753867
DOI
10.1371/journal.pone.0303048
License (as archived)
CC0-1.0
Archived
2026-10-06T18:30:52.772Z
SHA-256 of the archived text
a872e9da55efc851d7c9468f34d0dd3a35fb7119db64dc7504101edc0840c675
Stable URL of this page
https://metraipolis.com/documento/dc_20a1df330bce

How to cite

An integrated in-silico approach for drug target identification in human pathogen Shigella dysenteriae — Europe PMC PMID:38753867 — Europe PMC (en), https://europepmc.org/article/MED/38753867 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_20a1df330bce (Metraipolis archive dc_20a1df330bce, sha256 a872e9da55efc851d7c9468f34d0dd3a35fb7119db64dc7504101edc0840c675)
BibTeX
@misc{dc20a1df330bce,
  title = {An integrated in-silico approach for drug target identification in human pathogen Shigella dysenteriae — Europe PMC PMID:38753867},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38753867},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_20a1df330bce; sha256 a872e9da55efc851d7c9468f34d0dd3a35fb7119db64dc7504101edc0840c675},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38753867. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Shigella dysenteriae, is a Gram-negative bacterium that emerged as the second most significant cause of bacillary dysentery. Antibiotic treatment is vital in lowering Shigella infection rates, yet the growing global resistance to broad-spectrum antibiotics poses a significant challenge. The persistent multidrug resistance of S. dysenteriae complicates its management and control. Hence, there is an urgent requirement to discover novel therapeutic targets and potent medications to prevent and treat this disease. Therefore, the integration of bioinformatics methods such as subtractive and comparative analysis provides a pathway to compute the pan-genome of S. dysenteriae. In our study, we analysed a dataset comprising 27 whole genomes. The S. dysenteriae strain SD197 was used as the reference for determining the core genome. Initially, our focus was directed towards the identification of the proteome of the core genome. Moreover, several filters were applied to the core genome, including assessments for non-host homology, protein essentiality, and virulence, in order to prioritize potential drug targets. Among these targets were Integration host factor subunit alpha and Tyrosine recombinase XerC. Furthermore, four drug-like compounds showing potential inhibitory effects against both target proteins were identified. Subsequently, molecular docking analysis was conducted involving these targets and the compounds. This initial study provides the list of novel targets against S. dysenteriae. Conclusively, future in vitro investigations could validate our in-silico findings and uncover potential therapeutic drugs for combating bacillary dysentery infection.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-05-16).
Identificativi: PMID 38753867 · PMCID PMC11098424 · DOI 10.1371/journal.pone.0303048.
Descrittori MeSH principali: Shigella dysenteriae; Dysentery, Bacillary; Anti-Bacterial Agents; Computer Simulation; Molecular Docking Simulation.
Pagina: https://europepmc.org/article/MED/38753867 — https://doi.org/10.1371/journal.pone.0303048. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T16:55:36.121Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.